Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001861123-23-000001
Filing Date
2023-06-01
Accepted
2023-06-01 14:58:41
Documents
1
Effectiveness Date
2023-06-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14719
  Complete submission text file 0001861123-23-000001.txt   15732
Mailing Address 3929 POINT EDEN WAY HAYWARD CA 94545
Business Address 3929 POINT EDEN WAY HAYWARD CA 94545 415-865-2050
Eikon Therapeutics, Inc. (Filer) CIK: 0001861123 (see all company filings)

EIN.: 842807586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-483121 | Film No.: 23984309